Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Primo Nutraceuticals (BUGVF)
OTHER OTC:BUGVF
Holding BUGVF?
Track your performance easily
BUGVF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.11 - $0.11
Previous Close$0.11
Volume4.19K
Average Volume (3M)N/A
Market Cap
$26.00
Enterprise Value$326.64K
Total Cash (Recent Filing)C$9.95K
Total Debt (Recent Filing)C$465.93K
Price to Earnings (P/E)―
Beta0.00
Next Earnings
Jul 01, 2020EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding10,094,739
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation2.15
R-Squared0.00680
Alpha0.18
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BUGVF FAQ
What was Primo Nutraceuticals’s price range in the past 12 months?
Primo Nutraceuticals lowest stock price was $0.11 and its highest was $0.11 in the past 12 months.
What is Primo Nutraceuticals’s market cap?
Currently, no data Available
When is Primo Nutraceuticals’s upcoming earnings report date?
Primo Nutraceuticals’s upcoming earnings report date is Jul 01, 2020 which is 1606 days ago.
How were Primo Nutraceuticals’s earnings last quarter?
Primo Nutraceuticals released its earnings results on Feb 20, 2020. The company reported -$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.007.
Is Primo Nutraceuticals overvalued?
According to Wall Street analysts Primo Nutraceuticals’s price is currently Overvalued.
Does Primo Nutraceuticals pay dividends?
Primo Nutraceuticals does not currently pay dividends.
What is Primo Nutraceuticals’s EPS estimate?
Primo Nutraceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Primo Nutraceuticals have?
Primo Nutraceuticals has 25,982,025 shares outstanding.
What happened to Primo Nutraceuticals’s price movement after its last earnings report?
Primo Nutraceuticals reported an EPS of -$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Primo Nutraceuticals?
Currently, no hedge funds are holding shares in BUGVF
---
Company Description
Primo Nutraceuticals
Primo Nutraceuticals Inc is engaged in the production, processing, retail and branding of cannabis and cannabis related products. The company offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors.
---
Technical Analysis
---